Propanc Biopharma, Inc. Contracts & Agreements

Convertible Promissory Note dated December 8, 2023 (Filed With SEC on December 15, 2023)

Securities Purchase Agreement dated December 8, 2023 (Filed With SEC on December 15, 2023)

Convertible Promissory Note dated November 29, 2023 (Filed With SEC on December 7, 2023)

Securities Purchase Agreement dated November 29, 2023 (Filed With SEC on December 7, 2023)

8% Convertible Promissory Note, dated October 20, 2023, issued to the Investor (Filed With SEC on October 26, 2023)

Securities Purchase Agreement, dated as of October 20, 2023, by and between the Company and the Investor (Filed With SEC on October 26, 2023)

8% Convertible Redeemable Note, dated October 12, 2023, issued to the Investor (Filed With SEC on October 17, 2023)

Securities Purchase Agreement, dated as of October 12, 2023, by and between the Company and the Investor (Filed With SEC on October 17, 2023)

8% Convertible Redeemable Note, dated August 23, 2023, issued to the Investor (Filed With SEC on August 29, 2023)

Securities Purchase Agreement, dated as of August 23, 2023, by and between the Company and the Investor (Filed With SEC on August 29, 2023)

10% Original Issue Discount Promissory Note, dated August 15, 2023, issued to the August Lender (Filed With SEC on August 21, 2023)

8% Convertible Promissory Note, dated August 16, 2023, issued to the August Investor (Filed With SEC on August 21, 2023)

Securities Purchase Agreement, dated as of August 16, 2023, by and between the Company and the August Investor (Filed With SEC on August 21, 2023)

8% Convertible Promissory Note, dated July 19, 2023, issued to the Investor (Filed With SEC on August 8, 2023)

Securities Purchase Agreement, dated as of July 19, 2023, by and between the Company and the Investor (Filed With SEC on August 8, 2023)

Equity Line Agreement, dated July 20, 2023, by and between the Company and the Investor (Filed With SEC on July 26, 2023)

Registration Rights Agreement, dated July 20, 2023, by and between the Company and the Investor (Filed With SEC on July 26, 2023)

8% Convertible Promissory Note, dated June 29, 2023, issued to the June Investor (Filed With SEC on July 12, 2023)

Warrant, dated July 5, 2023 (Filed With SEC on July 12, 2023)

Securities Purchase Agreement, dated as of June 29, 2022, by and between the Company and the June Investor (Filed With SEC on July 12, 2023)

July Loan Agreement, dated July 5, 2023 (Filed With SEC on July 12, 2023)

Note, dated November 3, 2022, issued to the Investor (Filed With SEC on May 15, 2023)

Equity Line Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)

Securities Purchase Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)

Registration Rights Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)

Warrant Agreement, dated March 8, 2023, by and between the Company and the Warrant Holder (Filed With SEC on May 15, 2023)

10% Convertible Redeemable Note, dated February 14, 2023, issued by the Company to ONE44 Capital LLC (Filed With SEC on February 21, 2023)

Securities Purchase Agreement, dated February 14, 2023, by and between the Company and ONE44 Capital LLC (Filed With SEC on February 21, 2023)

Amended and Restated Employment Agreement, by and between the Company and James Nathanielsz, dated October 26, 2022 (Filed With SEC on November 1, 2022)

8% Convertible Promissory Note, dated October 6, 2022, issued by the Company to Red Road Holdings Corporation (Filed With SEC on October 12, 2022)

Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation (Filed With SEC on October 12, 2022)

8% Convertible Redeemable Note, dated September 21, 2022, issued by the Company to GS Capital Partners, LLC (Filed With SEC on September 27, 2022)

Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on September 27, 2022)

8% Convertible Redeemable Note, dated August 12, 2022, issued by the Company to GS Capital Partners, LLC (Filed With SEC on August 18, 2022)

10% Convertible Redeemable Note, dated August 15, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on August 18, 2022)

8% Convertible Promissory Note, dated June 30, 2022, issued by the Company to 1800 Diagonal Lending LLC (Filed With SEC on July 7, 2022)

Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on July 7, 2022)

8% Convertible Promissory Note, dated May 12, 2022, issued by the Company to 1800 Diagonal Lending LLC (Filed With SEC on May 18, 2022)

Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on May 18, 2022)

8% Convertible Promissory Note, dated April 12, 2022, issued by the Company to Sixth Street Lending LLC (Filed With SEC on April 18, 2022)

Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on April 18, 2022)

10% Convertible Redeemable Note, dated March 29, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on April 1, 2022)

Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC (Filed With SEC on April 1, 2022)

8% Convertible Promissory Note, dated March 7, 2022, issued by the Company to Sixth Street Lending LLC (Filed With SEC on March 10, 2022)

Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on March 10, 2022)

8% Convertible Promissory Note, January 3, 2022 (Filed With SEC on January 10, 2022)

Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on January 10, 2022)

10% Convertible Promissory Note, dated December 7, 2021, issued by the Company to ONE44 Lending LLC (Filed With SEC on December 13, 2021)

Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC (Filed With SEC on December 13, 2021)

Common Stock Purchase Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021 (Filed With SEC on December 7, 2021)

Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021 (Filed With SEC on December 7, 2021)

8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC (Filed With SEC on December 1, 2021)

Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on December 1, 2021)

Consultant Agreement by and between the Company and Paul Patrizio, dated October 1, 2021 (Filed With SEC on November 12, 2021)

8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC (Filed With SEC on October 27, 2021)

Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on October 27, 2021)

8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021 (Filed With SEC on August 18, 2021)

Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021 (Filed With SEC on August 18, 2021)

Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021 (Filed With SEC on August 18, 2021)

8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on January 11, 2021)

Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on January 11, 2021)

Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger (Filed With SEC on December 30, 2020)

Indemnification Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger (Filed With SEC on December 30, 2020)

8% Convertible Redeemable Promissory Note, dated December 10, 2020, issued by the Company to GW Holdings Group, LLC (Filed With SEC on December 16, 2020)

Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC (Filed With SEC on December 16, 2020)

8% Convertible Promissory Note, dated December 2, 2020, issued by the Company to Geneva Roth Remark Holdings, Inc (Filed With SEC on December 7, 2020)

Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on December 7, 2020)

Form of Prefunded Warrant (Filed With SEC on April 3, 2020)

Form of Series A Warrant (Filed With SEC on April 3, 2020)

Form of Series B Warrant (Filed With SEC on April 3, 2020)

Form of Series C Warrant (Filed With SEC on April 3, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 3, 2020)

Form of Registration Rights Agreement (Filed With SEC on April 3, 2020)

Form of First Convertible Redeemable Promissory Note (Filed With SEC on January 17, 2020)

Form of Second Convertible Redeemable Promissory Note (Filed With SEC on January 17, 2020)

Form of First Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of Second Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of Convertible Promissory Note (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)

Form of Convertible Redeemable Promissory Note (Filed With SEC on October 8, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 8, 2019)

Convertible Promissory Note, issued to Auctus Fund LLC on August 30, 2019 and effective as of September 3, 2019 (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 450,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 300,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Common Stock Purchase Warrant for the purchase of up to 225,000 shares of Propanc Biopharma, Inc.s common stock (Filed With SEC on September 9, 2019)

Securities Purchase Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC (Filed With SEC on September 9, 2019)

Registration Rights Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC (Filed With SEC on September 9, 2019)

10% Convertible Note made in favor of Odyssey Capital Funding LLC (Filed With SEC on August 6, 2019)

Securities Purchase Agreement dated July 30, 2019, by and between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC (Filed With SEC on August 6, 2019)

8% Convertible Promissory Note, dated July 3, 2019, issued by the Company to Power Up Lending Group Ltd (Filed With SEC on July 10, 2019)

Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd (Filed With SEC on July 10, 2019)

Employment Agreement, dated as of June 24, 2019, between Propanc PTY LTD and Carlo Campiciano (Filed With SEC on July 1, 2019)

Form of Warrant (Filed With SEC on June 14, 2019)

Form of Pre-Funded Warrant (Filed With SEC on June 14, 2019)

Form of Placement Agent Warrant (Filed With SEC on June 14, 2019)

Form of Securities Purchase Agreement (Filed With SEC on June 14, 2019)

Form of Placement Agency Agreement (Filed With SEC on June 14, 2019)

8% Convertible Promissory Note, dated May 23, 2019, issued by the Company to Redstart Holdings Corp (Filed With SEC on May 30, 2019)

Securities Purchase Agreement, dated May 23, 2019, by and between the Company and Redstart Holdings Corp (Filed With SEC on May 30, 2019)

Amended and Restated Employment Agreement, dated as of May 14, 2019, between the Company and James Nathanielsz (Filed With SEC on May 15, 2019)

Amended and Restated Services Agreement, dated as of May 14, 2019, between the Company and Dr. Julian Kenyon (Filed With SEC on May 15, 2019)

2019 Equity Incentive Plan (Filed With SEC on May 15, 2019)

Form of Indemnification Agreement (Filed With SEC on May 15, 2019)

Equity Purchase Agreement, dated February 25, 2019, by and between the Company and the Investor (Filed With SEC on February 25, 2019)

Registration Rights Agreement, dated February 25, 2019, by and between the Company and the Investor (Filed With SEC on February 25, 2019)

8% Convertible Redeemable Note, dated December 24, 2018, issued by the Company to Eagle Equities, LLC (Filed With SEC on December 28, 2018)

Securities Purchase Agreement, dated December 24, 2018, by and between the Company and Eagle Equities, LLC (Filed With SEC on December 28, 2018)

8% Convertible Redeemable Note, dated November 30, 2018, issued by the Company to Eagle Equities, LLC (Filed With SEC on December 6, 2018)

Securities Purchase Agreement, dated November 30, 2018, by and between the Company and Eagle Equities, LLC (Filed With SEC on December 6, 2018)

Equity Purchase Agreement, dated October 5, 2018, by and between the Company and the Investor (Filed With SEC on October 10, 2018)

Registration Rights Agreement, dated October 5, 2018, by and between the Company and the Investor (Filed With SEC on October 10, 2018)

8% Convertible Redeemable Note, dated October 2, 2018, issued by the Company to Eagle Equities, LLC (Filed With SEC on October 5, 2018)

8% Convertible Redeemable Note, dated October 2, 2018, issued by the Company to GS Capital Partners, LLC (Filed With SEC on October 5, 2018)

8% Convertible Redeemable Back End Note, dated October 2, 2018, issued by the Company to GS Capital Partners, LLC (Filed With SEC on October 5, 2018)

Collateralized Secured Promissory Note, dated October 2, 2018, issued by GS Capital Partners, LLC to the Company (Filed With SEC on October 5, 2018)

Securities Purchase Agreement, dated October 2, 2018, by and between the Company and Eagle Equities, LLC (Filed With SEC on October 5, 2018)

Securities Purchase Agreement, dated October 2, 2018, by and between the Company and GS Capital Partners, LLC (Filed With SEC on October 5, 2018)

Amendment No. 2 to Employment Agreement entered into as of September 25, 2017 by and between James Nathanielsz and the Company (Filed With SEC on September 17, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 4, 2018)

8% Convertible Redeemable Note issued to Power Up Lending Group Ltd (Filed With SEC on September 4, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC (Filed With SEC on September 4, 2018)

8% Convertible Redeemable Note issued to Eagle Equities, LLC (Filed With SEC on September 4, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC (Filed With SEC on July 19, 2018)

8% Convertible Redeemable Note (Filed With SEC on July 19, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Coventry Enterprises, LLC, dated as of June 29, 2018 (Filed With SEC on July 6, 2018)

8% Convertible Redeemable Note of Propanc Biopharma, Inc (Filed With SEC on July 6, 2018)

8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc (Filed With SEC on July 6, 2018)

Collateralized Secured Promissory Note of Coventry Enterprises, LLC (Filed With SEC on July 6, 2018)

8% Convertible Redeemable Note (Filed With SEC on July 2, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC (Filed With SEC on June 20, 2018)

8% Convertible Redeemable Note (Filed With SEC on June 20, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and GS Capital Partners, LLC, dated as of April 13, 2018 (Filed With SEC on April 19, 2018)

8% Convertible Redeemable Note of Propanc Biopharma, Inc (Filed With SEC on April 19, 2018)

8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc (Filed With SEC on April 19, 2018)

Collateralized Secured Promissory Note of GS Capital Partners, LLC (Filed With SEC on April 19, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and GS Capital Partners, LLC, dated as of March 23, 2018 (Filed With SEC on March 29, 2018)

8% Convertible Redeemable Note of Propanc Biopharma, Inc (Filed With SEC on March 29, 2018)

8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc (Filed With SEC on March 29, 2018)

Collateralized Secured Promissory Note of GS Capital Partners, LLC (Filed With SEC on March 29, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Power Up Lending Group Ltd (Filed With SEC on January 26, 2018)

8% Convertible Redeemable Note (Filed With SEC on January 26, 2018)

Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC (Filed With SEC on January 5, 2018)

8% Convertible Redeemable Note (Filed With SEC on January 5, 2018)

8% Convertible Redeemable Junior Subordinated Note due October 25, 2018 issued to Eagle Equities, LLC, dated November 3, 2017 (Filed With SEC on November 9, 2017)

8% Convertible Redeemable Junior Subordinated Back End Note due October 25, 2018 issued to Eagle Equities, LLC, dated November 3, 2017 (Filed With SEC on November 9, 2017)

Collateralized Secured Promissory Note (Bank End Note) due June 25, 2018 (Filed With SEC on November 9, 2017)

Securities Purchase Agreement by and between the Company and Eagle Equities, LLC, dated as of October 25, 2017 (Filed With SEC on November 9, 2017)

Letter Agreement dated September 30, 2017 between Propanc Biopharma, Inc. and Delafield Investments Limited (Filed With SEC on October 2, 2017)

8% Convertible Redeemable Junior Subordinated Promissory Note due September 12, 2018 issued to GS Capital, LLC (Filed With SEC on September 28, 2017)

8% Convertible Redeemable Junior Subordinated Promissory Note (Back End Note) due September 12, 2018 issued to GS Capital, LLC (Filed With SEC on September 28, 2017)

Amendment No. 2 to Employment Agreement entered into as of September 25, 2017 by and between James Nathanielsz and the Company (Filed With SEC on September 28, 2017)

Securities Purchase Agreement by and between the Company and GS Capital Partners, LLC, dated as of September 12, 2017 (Filed With SEC on September 28, 2017)

10%PER ANNUM, JUNIOR SUBORDINATED $310,000 CONVERTIBLE NOTE (Filed With SEC on August 15, 2017)

[Signaturepage follows] (Filed With SEC on August 15, 2017)

PROPANCBIOPHARMA, INC 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEJULY 24, 2018 (Filed With SEC on July 28, 2017)

PROPANCBIOPHARMA, INC 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEJULY 24, 2018 BACKEND NOTE (Filed With SEC on July 28, 2017)

GSCAPITAL PARTNERS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE BACKEND NOTE (Filed With SEC on July 28, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 28, 2017)

PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMAY 17, 2018 (Filed With SEC on June 1, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 1, 2017)

PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMARCH 1, 2018 (Filed With SEC on May 8, 2017)

PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMARCH 1, 2018 BACKEND NOTE (Filed With SEC on May 8, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 8, 2017)

40 Wall Street | New York, NY | 10005 p. 347 ###-###-#### | f. 646 ###-###-#### (Filed With SEC on March 21, 2017)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018 (Filed With SEC on February 3, 2017)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018 BACK END NOTE (Filed With SEC on February 3, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 3, 2017)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017 (Filed With SEC on December 30, 2016)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017 BACK END NOTE (Filed With SEC on December 30, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 30, 2016)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE PROMISSORY NOTE DUE DECEMBER 2, 2018 (Filed With SEC on December 7, 2016)

PROPANC HEALTH GROUP CORPORATION COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 7, 2016)

JUNIOR SUBORDINATED PROMISSORYNOTE (Filed With SEC on December 7, 2016)

PROPANC HEALTH GROUP CORPORATION UNSECUREDJUNIOR SUBORDINATED PROMISSORY NOTE DUE JUNE 1, 2017 (Filed With SEC on December 7, 2016)

[PROPANC HEALTH GROUP CORPORATION LETTERHEAD] (Filed With SEC on December 7, 2016)

EQUITY FINANCING AGREEMENT (Filed With SEC on December 7, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 7, 2016)

10%PER ANNUM, $250,000 JUNIOR SUBORDINATED CONVERTIBLE NOTE Note#1 (Filed With SEC on November 23, 2016)

10%PER ANNUM, $250,000 JUNIOR SUBORDINATED CONVERTIBLE NOTE Note#2 (Filed With SEC on November 23, 2016)

[Signaturepage follows.] (Filed With SEC on November 23, 2016)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017 (Filed With SEC on November 10, 2016)

PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017 BACK END NOTE (Filed With SEC on November 10, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 10, 2016)

EAGLE EQUITIES, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on November 10, 2016)

5%ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUEseptember 13, 2017 (Filed With SEC on September 16, 2016)

ADDITIONAL ISSUANCE AGREEMENT (Filed With SEC on September 16, 2016)

MANUFACTURING SERVICES AGREEMENT (Filed With SEC on August 23, 2016)

QUALITY ASSURANCE AGREEMENT (Filed With SEC on August 23, 2016)

COMMON STOCK PURCHASE WARRANT Propanc Health Group Corporation (Filed With SEC on August 4, 2016)

Level2, 555 Riversdale Road, Camberwell, Victoria, 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com (Filed With SEC on August 4, 2016)

Level 2, 555 Riversdale Road, Camberwell, Victoria 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com (Filed With SEC on July 5, 2016)

AMENDMENTNO. 1 TO EMPLOYMENTAGREEMENT (Filed With SEC on May 16, 2016)

EmploymentAgreement (Filed With SEC on March 25, 2016)

DirectorAgreement (Filed With SEC on March 25, 2016)

Dated 20XX PROPANC and [INSERT NAME] _______________________________________________ SCIENTIFIC ADVISORYBOARD MEMBER AGREEMENT _______________________________________________... (Filed With SEC on March 25, 2016)

ADDENDUM (Filed With SEC on March 11, 2016)

5%ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUEOctober 28, 2016 (Filed With SEC on November 3, 2015)

COMMON STOCK PURCHASE WARRANT PROPANCHEALTH GROUP CORP. (Filed With SEC on November 3, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 3, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 3, 2015)

SECURITY AGREEMENT (Filed With SEC on November 3, 2015)

PROMISSORY NOTE (Filed With SEC on September 29, 2015)

SECURITYAGREEMENT (Filed With SEC on September 29, 2015)

CERTIFICATE OF DESIGNATION OF SERIES B PREFERRED STOCK OF PROPANC HEALTH GROUP CORPORATION Pursuant to Section 151 of the Delaware General Corporation Law (Filed With SEC on July 15, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 10, 2016 (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 10, 2016 BACK END NOTE (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 17, 2016 (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 17, 2016 BACK END NOTE (Filed With SEC on April 13, 2015)

UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUPCORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 12, 2016 (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8%CONVERTIBLE REDEEMABLE NOTE DUE MARCH 12, 2016 BACK END NOTE (Filed With SEC on April 13, 2015)

UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 20, 2016 (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 20, 2016 BACK END NOTE (Filed With SEC on April 13, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 4, 2016 (Filed With SEC on April 13, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 13, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 13, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 13, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 13, 2015)

DEBT SETTLEMENT AGREEMENT (Filed With SEC on February 17, 2015)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 30 2015 (Filed With SEC on September 22, 2014)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 30, 2015 BACK END NOTE (Filed With SEC on September 22, 2014)

UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on September 22, 2014)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29 2015 (Filed With SEC on September 22, 2014)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29, 2015 BACK END NOTE (Filed With SEC on September 22, 2014)

LG CAPITAL FUNDING, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on September 22, 2014)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29 2015 (Filed With SEC on September 22, 2014)

PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29, 2015 BACK END NOTE (Filed With SEC on September 22, 2014)

ADAR BAYS, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE (Filed With SEC on September 22, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 22, 2014)

SETTLEMENT AGREEMENT AND STIPULATION (Filed With SEC on September 22, 2014)

EQUITY PURCHASE AGREEMENT BY AND BETWEEN PROPANC HEALTH GROUP CORPORATION AND SOUTHRIDGE PARTNERS II LP Dated July __, 2014 (Filed With SEC on September 22, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 22, 2014)

Escrow Agreement with Signature Bank (Filed With SEC on December 8, 2011)

Form of Subscription Agreement (Filed With SEC on November 14, 2011)

Limited Distributor Deed (Filed With SEC on October 27, 2011)

Investment Banking & Listing Agreement between Propanc Health Group Corporation and Churchill and Associates, LLC dated August 3, 2010 (Filed With SEC on October 27, 2011)

Investment Banking & Listing Agreement between Propanc Health Group Corporation and Churchill and Associates, LLC dated September 16, 2010 (Filed With SEC on October 27, 2011)

Termination Letter (Filed With SEC on October 27, 2011)

EXHIBIT 10.12 UNIVERSITY OF BATH Dated: 18 July 2008 (1) UNIVERSITY OF BATH (2) PROPANC PTY LTD RESEARCH AGREEMENT IN THE DEPARTMENT OF BIOLOGY AND BIOCHEMISTRY RELATING TO... (Filed With SEC on August 18, 2011)

MD Employment Agreement Schedule (Filed With SEC on June 23, 2011)

OFFER TO EXCHANGE SHARES OF PROPANC PTY LTD FOR COMMON STOCK OF PROPANC HEALTH GROUP CORPORATION 576 Swan Street Richmond, VIC, 3121, AUSTRALIA Attention: James Nathanielsz, CEO... (Filed With SEC on June 23, 2011)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 23, 2011)

EXCHANGE OFFER SUBSCRIPTION AGREEMENT NON-U.S. PERSON (Filed With SEC on June 23, 2011)

Category

Industry

Companies

Contracts

Propanc Biopharma, Inc. Contracts & Agreements